Bio-pharma Market
Bio-pharma Market Scope: Industry Analysis, Market
Size, Growth, Trends Till 2031
Request Sample Report
Bio-pharma Market Size and Growth
The bio-pharma market is experiencing robust growth, driven by increasing demand for innovative therapies and advanced biotechnologies. The market size was valued at approximately $400 billion in 2022, with projections to reach around $600 billion by 2028. Comprehensive market research highlights trends, challenges, and opportunities shaping this dynamic industry.
Companies Covered
(Covid 19 Impact Covered)
◍ Pfizer
◍ F. Hoffmann-La Roche AG
◍ Johnson & Johnson Services
◍ Sanofi, Amgen
◍ AbbVie
◍ Merck & Co., Inc
◍ Biogen Idec
◍ Bayer AG
◍ Eli Lilly and Company
◍ Novartis AG GlaxoSmithKline Plc
◍ Bristol-Myers Squibb Company
◍ AstraZeneca PLC
◍ Abbott Laboratories
The bio-pharma market includes major players like Pfizer and Roche, focusing on innovative therapeutics. Companies like Johnson & Johnson and Merck develop biologics and biosimilars, driving market growth. Key sales revenues include Pfizer ($81 billion), Roche ($67 billion), and AbbVie ($56 billion), contributing significantly to industry expansion.
Request Sample Report
Market Segmentation
By Application By Product
◍ Metabolic Disorders
◍ Oncology
◍ Neurological Disorders
◍ Cardiovascular Diseases
◍ Inflammatory and Infectious Diseases
◍ Others
◍ Monoclonal Antibodies
◍ Recombinant Proteins
◍ Granulocyte-Colony Stimulating Factor (G-CSF)
◍ Interferons
◍ Recombinant Human Insulin
◍ Erythropoietin
◍ Vaccines
◍ Growth Hormones
◍ Purified Proteins
◍ Others
Market Growth
Request Sample Report
$ X Billion USD
